NCT02022215 - Efficacy and Safety Study of ME1111 in Patients With Onychomycosis | Biotech Hunter

Enrollment

304

Participants

Timeline

Start Date

December 19, 2013

Primary Completion Date

October 28, 2015

Study Completion Date

March 1, 2016

Conditions

Onychomycosis

Interventions

DRUG

ME1111 Solution, Low strength

ME1111 Solution, Low strength, applied once daily for 48 weeks

DRUG

ME1111 Solution, High strength

ME1111 Solution, High strength, applied once daily for 48 weeks

DRUG

Matching Vehicle Solution

Matching Vehicle Solution, applied once daily for 48 weeks

Trial Locations (31)

Unknown

Birmingham

Encinitas

San Diego

San Francisco

Santa Rosa

Denver

Miami

Miramar

Newnan

Boise

Evansville

Baltimore

Ann Arbor

Clinton Township

Fridley

Albuquerque

New York

Rochester

Cincinnati

Portland

Mt. Pleasant

Knoxville

Nashville

Austin

College Station

Dallas

San Antonio

Salt Lake City

Lynchburg

Norfolk

Spokane